News | Diabetes

News

Generic weight loss drugs could alleviate shortages, says BGMA

Although the British Generic Manufacturers Association anticipates at least four companies receiving UK marketing authorisations for type 2 diabetes and obesity, it remains unclear how many will be rolled out immediately.…

Published: 22 November 2024

News

Manufacturer confirms discontinuation of type 2 diabetes mellitus treatment Victoza

Victoza (liraglutide) 6mg/mL pre-filled injection pens have been out of stock in the UK since August 2023.…

Published: 21 October 2024

News

Problems with diabetes monitoring devices are potentially being underreported, says MHRA

The regulator has urged people to speak to a healthcare professional if they have concerns that their health may have been impacted by an issue with their device.…

Published: 10 October 2024

News

Pharmacy-led national diabetes screening service could save NHS £50m a year, says CCA

The Company Chemists’ Association said pharmacies across England could screen up to 1.5 million adults annually.…

Published: 20 September 2024

News

Weekly insulin injection as effective as daily injections in type 1 and type 2 diabetes, research suggests

Two studies have suggested that a once-weekly injection of insulin has a similar effectiveness for blood sugar management as daily injections.…

Published: 11 September 2024

News

MHRA finds no link between GLP-1 receptor agonists and suicidal behaviour

The regulator says it will continue to monitor the risk of severe psychiatric reactions and assess new data as they become available.…

Published: 6 September 2024

News

Suicidal ideation more commonly reported as reaction to semaglutide than for all other drugs, study finds

Researchers report that, for people taking antidepressants, suicidal ideation was reported 4.45 times as likely for semaglutide compared with adverse drug reactions from all other drugs.…

Published: 23 August 2024

News

Almost one-third of people on low-calorie diet programme in remission from type 2 diabetes mellitus, study results show

Since its nationwide roll-out in May 2024, NHS England says more than 25,000 people have been referred to take part in the ‘Type 2 diabetes path to remission programme’.…

Published: 6 August 2024

News

Seven in ten pharmacists say medicines shortages have put patients at risk in past six months

Exclusive: Responding to a survey of 1,265 UK-based pharmacists working in all sectors, 861 answered ‘Yes’ when asked if medicines shortages have put patients at risk “in the past six months”.…

Published: 19 July 2024

News

Semaglutide linked to sight-threatening eye condition, study results suggest

Researchers used data from nearly 17,000 patients to examine whether semaglutide prescriptions were associated with increased risk of non-arteritic anterior ischemic optic neuropathy in patients with type 2 diabetes mellitus, obesity, or who were overweight.…

Published: 4 July 2024